Evaluating the administration costs of biologic drugs: development of a cost algorithm.

about

Discrete-choice modelling of patient preferences for modes of drug administration Subcutaneous drug delivery: An evolving enterprise.Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.

P2860

Q41158364-9D9F2259-7B36-41FB-8866-E904FA7BDA6F Q47737747-773363E8-35C7-437C-8479-CE412F6798B6 Q49391770-48E85EF6-657E-410F-B1BD-EAC53FA415CF

P2860

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

Item

http://www.wikidata.org/entity/Q36944368

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

@en

type

Item

label

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

@en

prefLabel

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

@en

P1476

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

@en

P2093

Ebenezer K Tetteh

http://www.w3.org/2001/XMLSchema#string

P2860

Parametric modelling of cost data in medical studies.

Multiple regression of cost data: use of generalised linear models.

Generalized modeling approaches to risk adjustment of skewed outcomes data.

Pharmacoeconomics of intravenous drug administration.

The economic value of reducing medication dosing frequency with drug delivery technologies: an evidence assessment.

Development of a subcutaneous formulation for trastuzumab - nonclinical and clinical bridging approach to the approved intravenous dosing regimen.

Systematic review of drug administration costs and implications for biopharmaceutical manufacturing.

New models for old questions: generalized linear models for cost prediction.

Uncertainty and the demand for medical care.

Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer.

P2888

s13561-014-0026-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13561-014-0026-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen Morris

P577

2014-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280387972

http://www.w3.org/2001/XMLSchema#string

P6179

1012089390

http://www.w3.org/2001/XMLSchema#string

P698

26208926

http://www.w3.org/2001/XMLSchema#string

P932

4883988

http://www.w3.org/2001/XMLSchema#string

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

about

P2860

P2860

Evaluating the administration costs of biologic drugs: development of a cost algorithm.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P932